Press coverage about ITUS Corporation (NASDAQ:ITUS) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. ITUS Corporation earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave news articles about the business services provider an impact score of 43.4442379526913 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Shares of ITUS Corporation (NASDAQ ITUS) traded down 2.38% on Friday, hitting $0.73. 60,918 shares of the stock were exchanged. The firm’s market capitalization is $11.04 million. ITUS Corporation has a one year low of $0.60 and a one year high of $6.82. The company has a 50-day moving average price of $0.77 and a 200-day moving average price of $1.88.

ILLEGAL ACTIVITY WARNING: “ITUS Corporation (ITUS) Receives Daily Media Sentiment Score of 0.15” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at

ITUS Corporation Company Profile

ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient’s immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream.

Insider Buying and Selling by Quarter for ITUS Corporation (NASDAQ:ITUS)

Receive News & Stock Ratings for ITUS Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITUS Corporation and related stocks with our FREE daily email newsletter.